EHA 2018 Multiple Myeloma Abstracts –
Poster Presentations On June 15
There will be two sessions at the 2018 European Hematology Association (EHA) meeting where posters focused on multiple myeloma-related research will be displayed and visitors to the poster hall can speak with one of the poster's authors. The first session will be in the late afternoon on Friday, June 15. The second will be in the late afternoon on Saturday, June 16.
Listed below are titles and links to the abstracts for the myeloma-related posters that will be on display on Friday, June 15. A separate list is available for posters to be presented on Saturday, June 16. Both lists include transplantation-related posters with either direct or indirect relevance to multiple myeloma.
The Beacon also has a list of EHA 2018 myeloma-related "e-posters," and a list of all myeloma-related oral presentations.
Links to PDF files containing posters will be added to entries in this list as those files are made available to The Beacon courtesy of the EHA presenters.
| Session | Gene Therapy, Cellular Immunotherapy and Vaccination – Biology & Translational Research |
| Type | Poster Presentations |
| Time | Friday June 15, 5:30 PM - 7:00 PM |
| Location | Poster Area |
PF393 – Antitumor Activity By TEGs: Alpha/Beta T Cells Engineered To Express A Defined Gamma/Delta TCR In A 3d Bone Marrow Niche Model Of Multiple Myeloma
Trudy Straetemans, Maaike Braham, Tineke Aarts-Riemens, Jaqueline Alblas, Monique Minnema, Zsolt Sebestyen, Jurgen Kuball (abstract)
PF396 – Lenalidomide And Programmed Death-1 Blockade Synergistically Enhances The Effects Of Dendritic Cell Vaccination In A Model Of Murine Myeloma
Sung-Hoon Jung, Je-Jung Lee, Manh-Cuong Vo, Tan-Huy Chu, Hyun-Ju Lee, Thangaraj Jaya Lakshmi, Hye-Sung Park, Hyeoung-Joon Kim, Joon Haeng Rhee (abstract)
PF399 – Early MRD Negativity Predicts Deepening Myeloma Response In Relapsed / Refractory Multiple Myeloma (RRMM) Patients Treated With bb2121 Anti-BCMA CAR T Cells.
Nikhil Munshi, Jesus Berdeja, Yi Lin, James M. Kochenderfer, Noopur Raje, Michaela Liedtke, Sundar Jagannath, Deepu Madduri, Jacalyn Rosenblatt, Marcela Maus, Ashley Turka, Lyh Ping Lam, Kristen Hege, Timothy Campbell, Monica Massaro, Fabio Petrocca, David Siegel (abstract)
| Session | Hematopoiesis, Stem Cells and Microenvironment |
| Type | Poster Presentations |
| Time | Friday June 15, 5:30 PM - 7:00 PM |
| Location | Poster Area |
PF419 – Prospectively Isolated Bone Marrow Stromal Cells From Patients With Hematological Malignancies Differ Phenotypically And Relate To Disease Stage In MGUS/Myeloma
Dimitra Zacharaki, Roshanak Ghazanfari, Hongzhe Li, Hooi Ching Lim, Sofia von Palffy, Shamit Soneji, Thoas Fioretos, Stefan Scheding (abstract)
| Session | Infectious Diseases, Supportive Care |
| Type | Poster Presentations |
| Time | Friday June 15, 5:30 PM - 7:00 PM |
| Location | Poster Area |
PF455 – Invasive Aspergillosis In Haematological Patients: A Review Of 625 Cases
Céline Duval, Marie-Pierre Ledoux, François Danion, Guillaume Morel, Blandine Guffroy, Célestine Simand, Elise Toussaint, Agnès Cazes, Margot Lamothe, Julie Denis, Valérie Letscher-Bru, Luc-Matthieu Fornecker, Raoul Herbrecht (abstract)
PF463 – The Role Of Serum Galactomannan Assay In The Management Of Invasive Mold Infections In Autologous Hematopoietic Cell Transplantation.
Maria Esther Martinez-Muñoz, Francisca Portero, Emilio Ojeda, Guiomar Bautista, Rafael Forés, Isabel Krsnik, Almudena de Laiglesia, Belén Navarro, Antonio Ramos, Jose Rafael Cabrera, Rafael Duarte (abstract)
PF464 – Cytomegalovirus (CMV) Impact On Clinical Outcomes And Resource Use After Allogeneic Hematopoietic Cell Transplantation: The Influence Of Recurrent Episodes Of CMV Infection
Carlos de Miguel, Ana Royuela, María Francsica Portero, Juan Luis Cruz, María Esther Martínez-Muñoz, María Isabel Sánchez-Romero, Guiomar Bautista, Rafael Cabrera, Rafael F Duarte (abstract)
PF467 – Post-Transplant Epstein-Barr Viral Load Monitoring Experience In A Hematopoietic Stem Cell Transplantation Center
Mürüvvet Seda Aydın, Ahmet Cagkan Inkaya, Elifcan Karakulak, Rafiye Çiftçiler, Mehmet Turgut, Hakan Goker, Engin Kelkitli, Haluk Demiroglu, Yahya Buyukasik, Nilgun Sayinalp (abstract)
| Session | Myeloma and Other Monoclonal Gammopathies – Biology & Translational Research |
| Type | Poster Presentations |
| Time | Friday June 15, 5:30 PM - 7:00 PM |
| Location | Poster Area |
PF511 – Mutations In 19s Proteasome Subunits Represent A Novel Mechanism Of Acquired Resistance To Proteasome Inhibitors In Multiple Myeloma Patients
Santiago Barrio, Michal Simicek, Matteo DaVia, Katerina Growkova, Max Bittrich, Hermann Einsele, Roman Hajek, K. Martin Kortüm (abstract)
PF512 – Expression Of P53 Isoforms At mRNA Level In Multiple Myeloma: Implications For Clinical Outcome
Elizabeta De Los Angeles Rojas, Luis Antonio Corchete, Cristina De Ramón, Ana Belén Herrero, Dalia Qwaider, Patryk Krzeminski, Joaquín Martínez-López, Ramón García-Sanz, Joan Bladé, Juan-José Lahuerta, Jesús San Miguel, María Victoria Mateos, Irena Misiewicz-Krzeminska, Norma C. Gutiérrez (abstract)
PF513 – KRAS But Not NRAS Mutations Are Associated With A Favorable Overall Survival In Newly Diagnosed Multiple Myeloma Patients Treated With Intensive Therapy
Christian Langer, Linda Röhner, Anna Dolnik, Swantje Held, Miriam Kull, Veronica Teleanu, Donald Bunjes, Denise Miller, Simon Köpff, Martin Schreder, Lars-Olof Mügge, Monika Engelhardt, Florian Bassermann, Hartmut Döhner, Ralf Bargou, Hermann Einsele, Lars Bullinger, Stefan Knop, Jan Krönke (abstract)
PF514 – ADAR1-Mediated-A-to-I-Editing Is Biologically And Clinically Relevant In Multiple Myeloma
Phaik Ju Teoh, Omer An, Tae-Hoon Chung, Jing Yuan Chooi, Sabrina Toh, Shuangyi Fan, Leilei Chen, Siok Bian Ng, Henry Yang, Wee Joo Chng (abstract)
PF515 – Molecular Mechanisms Of The Activity Of The Novel c-Myc Targeted-Compound IDP-501 In MM
Patryk Krzeminski, Lorena González Méndez, Laura San Segundo, Pedro Mogollón, Andrea Díaz, Susana Hernández-García, Macarena Algarín, Montserrat Martín-Sánchez, Luis Corchete, Teresa Paíno, Norma C Gutiérrez, Mª Victoria Mateos, Laura Nevola, Santiago Esteban, Mercedes Garayoa, Enrique M Ocio (abstract)
PF516 – SNPs Array Analysis Of Copy Number Alterations (CNAs) In Newly Diagnosed Transplant-Eligible Multiple Myeloma (MM) Patients: Definition Of A Prognostic Risk-Classifier.
Carolina Terragna, Vincenza Solli, Andrea Poletti, Marina Martello, Barbara Santacroce, Anna Baraldi, Luca Dozza, Adelina Sementa, Alessandra Larocca, Lucia Pantani, Norbert Pescosta, Paola Tacchetti, Giovanna Leonardi, Elena Zamagni, Rosalinda Termini, Caterina Musolino, Enrica Borsi, Giulia Marzocchi, Letizia Canepa, Gaia Ameli, Beatrice Anna Zannetti, Anna Pascarella, Luca De Rosa, Nicoletta Testoni, Giovanni Martinelli, Piter Sonneveld, Michele Cavo (abstract)
PF517 – Peptide Stimulation Of PD-L1 Specific T Cells Naturally Occuring In Myeloma Patients Augment The ADCC Activity Of Daratumumab
Nicolai Grønne Jørgensen, Shamaila Munir Ahmad, Simone Kloch Bendtsen, Evelina Martinenaite, Morten Orebo Holmström, Pernille Andersen, Özcan Met, Mads Hald Andersen (abstract)
PF518 – Novel Kinase Inhibitors Afuresertib And pim447 Are Active In A Predictive Myeloma In Vivo Model, And A CRISPR Genome-Wide Screening Approach Identifies Biomarkers Determining Susceptibility
Niamh Keane, Meaghen Sharik, Alessandro Natoni, Marta Chesi, Leif Bergsagel, O'Dwyer Michael (abstract)
PF519 – CD26 Is A Potential Therapeutic Target By Humanized Monoclonal Antibody In Multiple Myeloma
Hiroko Nishida, Mutsumi Hayashi, Hiroshi Suzuki, Michiie Sakamoto, Taketo Yamada (abstract)
PF520 – DNA Repair Processes Target Transcribed Region In Multiple Myeloma
Mehmet Samur, Raphael Szalat, Matthew Lawlor, Francesco Maura, Christopher Ott, Niccolo Bolli, Kenneth Anderson, Stephane Minvielle, Peter Campbell, Hervé Avet-Loiseau, Nikhil Munshi (abstract)
PF521 – Effect Of Daratumumab On Normal Plasma Cells, Polyclonal Immunoglobulins And Vaccination Responses In Extensively Pretreated Myeloma Patients
Kristine Frerichs, Patricia Bosman, Jeroen van Velzen, Inger Nijhof, Andries Bloem, Tuna Mutis, Sonja Zweegman, Niels van de Donk (abstract)
PF522 – Study Of Plasma Cell Trascriptome In Smoldering Myeloma Patients In Relationship To Progression To Active Multiple Myeloma.
Paola Storti, Benedetta Dalla Palma, Katia Todoerti, Luca Agnelli, Valentina Marchica, Marina Bolzoni, Federica Costa, Denise Toscani, Emanuela Vicario, Gabriella Sammarelli, Fabrizio Accardi, Giannalisa Todaro, Laura Notarfranchi, Ilenia Manfra, Federica De Luca, Luisa Craviotto, Franco Aversa, Antonino Neri, Nicola Giuliani (abstract)
PF523 – Genomic Characterization Of Hematopoietic Stem And Progenitor Cells In Multiple Myeloma Reveals Distinct Patterns Of Disease Evolution
Aino-Maija Leppä, Samuli Eldfors, Pekka Anttila, Caroline Heckman (abstract)
PF524 – Longitudinal Chromosomal Abnormalities Analysis In Multiple Myeloma Disease Progression Reveals Clonal Evolution After Therapy.
Stefania Oliva, Caltagirone Simona, Marina Ruggeri, Giusy Cetani, Stefano Spada, Daniela Oddolo, Rossella Troia, Eleonora Marzanati, Giulia Gazzera, Milena Gilestro, Elona Saraci, Chiara Pautasso, Vittorio Muccio, Sara Bringhen, Mario Boccadoro, Paola Omedé (abstract)
PF525 – myTYPE Targeted Next Generation Sequencing Assay For Detection Of IgH Translocations And Copy Number Alterations In Multiple Myeloma
Malin Hultcrantz, Venkata Yellapantula, Even Holth Rustad, Heather Landau, Christine Iacobuzio-Donahue, Theresia Akhlaghi, Ido Amit, Guy Ledergor, Neha Korde, Sham Mainlankody, Dickran Kazandjian, Akshar Patel, Niccolo Bolli, Elli Papaemmanuil, Ola Landgren (abstract)
PF526 – Rapid And Scalable Genome-Wide Profiling Of Clinically Relevant Genetic Aberrations In Multiple Myeloma
Donat Alpar, Lilit Atanesyan, Szabolcs Kosztolanyi, Richard Kiss, Ambrus Gango, Karel de Groot, Maryvonne Steenkamer, Pal Jakso, Andras Matolcsy, Bela Kajtar, Laszlo Pajor, Karoly Szuhai, Suvi Savola, Csaba Bodor (abstract)
PF527 – Induction Of Structural And Functional Effects On Myeloma Cells After Daratumumab Treatment
Angelo Corso Faini, Barbara Castella, Yuliya Yakymiv, Alberto L. Horenstein, Cristiano Bracci, Fabio Morandi, Alessandra Larocca, Stefania Oliva, Massimo Massaia, Mario Boccadoro, Fabio Malavasi (abstract)
PF528 – RNA-seq Based Risk Stratification In Multiple Myeloma Patients Validates SKY92 As A High Risk Marker In The CoMMpass Trial
Rowan Kuiper, Martin H. van Vliet, Mark van Duin, Erik H. van Beers, Pieter Sonneveld (abstract)
PF529 – MDSCs Contribute To Cancer Stem Cells Accumulation Via piRNA 823 Upregulation And De Novo DNA Methylation In Multiple Myeloma
Lisha Ai, Shidai Mu, Yu Hu (abstract)
PF530 – Mesenchymal Stromal Cell Sialyation Enhances Immune Suppression: Implications In Multiple Myeloma
Kevin Lynch, Kim De Veirman, Grace O'Malley, Karin Vanderkerken, Aideen Ryan, Michael O'Dwyer, Thomas Ritter (abstract)
PF531 – Low-Pass Sequencing Of Plasma Cell DNA And Of Circulating Cell-Free DNA For The Detection Of Copy Number Aberrations And Early Response Monitoring In Multiple Myeloma
Barbara Dewaele, Sanne Smits, Lucienne Michaux, Michel Delforge, Geneviève Ameye, Luc Dehaspe, Nathalie Brison, Jia Ding, Stefan Lehnert, Nancy Boeckx, Jeroen Van Houdt, Joris Vermeesch, Peter Vandenberghe (abstract)
PF532 – RNA-seq Analysis Unravels Specific Long Non-Coding RNA Transcriptional Fingerprints In Multiple Myeloma Subtypes
Elisa Taiana, Cristina Vinci, Valeria Ferla, Domenica Ronchetti, Alessandra Pompa, Katia Todoerti, Martina Manzoni, Lucia Nobili, Vanessa Favasuli, Agostino Cortelezzi, Luca Baldini, Antonino Neri, Luca Agnelli (abstract)
PF533 – Combination Targeting Of Sialylation And The Proteasome Inhibits Tumor Growth And Increases Survival In A Humanized Mouse Multiple Myeloma Model
Michaela Reagan, Mariah Farrell, Matthew Macauley, Alessandro Natoni, Heather Fairfield, Michael O'Dwyer (abstract)
PF534 – Activation Of NFAT (Nuclear Factor Of Activated T Cells) Signaling And Induction Of Autophagy Confer Bortezomib Resistance In Multiple Myeloma
Margaret Ng, Kin-Mang Lau, Chi-Keung Cheng, Nelson Chan, Jenny Xia (abstract)
PF535 – The Conical Agarose Microwell Array (CAMA) Enables 3d Long-term Cultivation Of Primary Samples And Enhanced High Throughput Screening For Rational Epigentic/Antibody Combination In Multiple Myeloma
Stefan J. Mueller, Dagmar Wider, Marie Follo, Sandra M. Dold, Cornelius Miething, Gabriele Ihorst, Johannes M. Waldschmidt, Julia Felthaus, Julia Schueler, Andreas R. Thomsen, Abdel Kareem Azab, Justus Duyster, Martin J. Hug, Manfred Jung, Ralph Waesch, Monika Engelhardt (abstract)
PF536 – Enhanced Cytotoxicity Of Multiple Myeloma Cells Using Daratumumab In Combination With NK Cells Engineered To Express High-Affinity CD16 (F158v)
Sachin Chauhan, Subhashis Sarkar, Tony Duggan, John Daly, Michael O'Dwyer (abstract)
PF537 – Immunological Profiling By Mass Cytometry Reveals That TIM3 Expression Is Reduced On NK Cell Subsets In Newly Diagnosed Myeloma And Is Associated With Loss Of NK Function And Decreased Survival
Frances Seymour, Jamie Cavenagh, John Gribben (abstract)
PF538 – Autologous Stem Cell Transplantation As A Model For Accelerated T-Cell Aging
Fabienne Lucas, Jennifer Woyach, Suohui Zhang, Xiangnan Guan, Christin Burd, Don Benson, Yvonne Efebera, Ashley Rosko (abstract)
PF540 – MDSCs Promoted Tumorigenesis Of Multiple Myeloma Both In Vitro And In Vivo.
Lisha Ai, Shidai Mu, Yu Hu (abstract)
PF541 – Targeting The Interaction Of Multiple Myeloma And The Bone Marrow Microenvironment Through Novel Small Molecules Directed To Notch Pathway
Natalia Platonova, Chiara Parravicini, Luca Palazzolo, Alessandro Paoli, Simona Saporiti, Michela Colombo, Veronica Vallelonga, Domenica Giannandrea, Antonino Neri, Ivano Eberini, Raffaella Chiaramonte (abstract)
PF542 – Expression Levels Of The Three Genes CRBN, IKZF1, And IKZF3 In Primary Multiple Myeloma Cells At Pre- And Post- Lenalidomide Treatment
Shiori Kinoshita, Masaki Ri, Takashi Kanamori, Sho Aoki, Takashi Yoshida, Tomoko Narita, Haruhito Totani, Asahi Ito, Shigeru Kusumoto, Hirokazu Komatsu, Shinsuke Iida (abstract)
PF543 – MYC Involves Multiple Myeloma Progression By Attenuating Tumor Suppressive Function Of Tp53-Micro RNA 34 Axis
Hiroshi Handa, Yuki Murakami, Kei Masuda, Tsukasa Oda, Yuta Masuda, Hikaru Hattori, Rei Ishihara, Kazuki Honma, Saki Watanabe, Yuko Kuroda, Nobuhiko Kobayashi, Takuma Ishizaki, Hiroaki Shimizu, Hiromi Koiso, Yohei Osaki, Akihiko Yokohama, Norifumi Tsukamoto, Tetsuhiro Kasamatsu, Takayuki Saitoh, Hirokazu Murakami (abstract)
PF544 – Preventing And Repairing Myeloma Bone Disease By Combining Conventional Anti-Resorptive Treatment With A Novel Bone Anabolic Treatment
Andrew Chantry, Julia Paton-Hough, Simon Tazzyman, Holly Evans, Lath Darren, Jenny Down, Green Alanna, Snowden John, Michelle Lawson (abstract)
PF545 – Tryptophan Shortage Due To IDO-1 Expressed By High-Density Neutrophils Induce Immune-Suppression And Plasma Cell Fitness In Multiple Myeloma
Alessandra Romano, Piera La Cava, Nunziatina Laura Parrinello, Cesarina Giallongo, Daniele Tibullo, Giuseppina Camiolo, Fabrizio Puglisi, Valeria Calafiore, Marina Parisi, Vittorio Del Fabro, Claudia Bellofiore, Giuseppe Sapienza, Floriana Cremasco, Concetta Conticello, Giuseppe Alberto Palumbo, Simone Cenci, Francesco Di Raimondo (abstract)
PF546 – Characterization Of ST3GAL6-AS1, A Novel lncRNC Deregulated In Multiple Myeloma
Cristina Vinci, Elisa Taiana, Vanessa Favasuli, Domenica Ronchetti, Luca Agnelli, Serena Galletti, Martina Manzoni, Francesca Pelizzoni, Marta Lionetti, Katia Todoerti, Antonino Neri (abstract)
PF547 – Multiple Myeloma Related Angiogenesis: Role Of Notch-Jag Axis In Modulating Endothelial Cells Behavior
Maria Teresa Palano, Michela Colombo, Natalia Platonova, Antonino Neri, Raffaella Chiaramonte (abstract)
PF548 – Adiporon, The First Oral Adiponectin Receptor Agonist, Inhibits The Proliferation Of Myeloma Cells Via The AMPK / mTOR / Autophagy Signaling Pathway
Shujuan Wang, Yanfang Liu (abstract)
PF549 – Clinical Relevance Of Long Non Coding RNA In Multiple Myeloma: Retrospective Monocentric Study
Valeria Ferla, Alessandra Pompa, Luca Agnelli, Francesca Rossi, Francesca Guidotti, Anna Ines Gregorini, Sonia Fabris, Marzia Barbieri, Marta Lionetti, Katia Todoerti, Martina Manzoni, Agostino Cortelezzi, Antonino Neri, Luca Baldini (abstract)
PF550 – Drug Sensitivity Screening In Multiple Myeloma (MM) For Precision Cancer Therapy
Deepak Balaji Thimiri Govinda Raj, Mariaserena Giliberto, Andrea Cremaschi, Sigrid S Skånland, Alexandra Gade, Dong Wang, Geir E Tjønnfjord, Fredrik Schjesvold, Ludvig A Munthe, Kjetil Tasken (abstract)
PF551 – Assessment Of Selected Toll-Like Receptors Expression On T And B Lymphocytes In Patients With Monoclonal Gammopathy Of Undetermined Significance
Ewelina Grywalska, Marcin Pasiarski, Pawel Steckiewicz, Agnieszka Stelmach-Goldys, Barbara Sosnowska-Pasiarska, Krzysztof Gosik, Anna Kowalska, Bartosz Garus, Stanislaw Gozdz, Jacek Rolinski (abstract)
PF552 – Discovery Blood Plasma Proteomics In Elucidating Biomarkers To Distinguish Onset Of Lethal Multiple Myeloma In Premalignant MGUS
Luz Yurany Moreno, Nicola J Weston-Bell, Kate Vandyke, Duncan Hewett, Andrew Zannettino, Spiros Garbis, Surinder Sahota (abstract)
| Session | Myeloma and Other Monoclonal Gammopathies – Clinical |
| Type | Poster Presentations |
| Time | Friday June 15, 5:30 PM - 7:00 PM |
| Location | Poster Area |
PF554 – Single Agent Carfilzomib Prolongs PFS Following Triplet Therapy With Cyclophosphamide & Dexamethasone For First Relapse / Primary Refractory Multiple Myeloma: Phase 2 MUKfive Study, Second Analysis
Kwee Yong, Samantha Hinsley, Debbie Sherratt, Sarah Brown, Louise Flanagan, Catherine Williams, Jamie Cavenagh, Martin Kaiser, Neil Rabin, Karthik Ramasamy, Mamta Garg, Holger Auner, Stephen Hawkins, Ceri Bygrave, Ruth De Tute, Gareth Morgan, Faith Davies, Roger Owen (abstract)
PF555 – Subcutaneous Daratumumab In Patients With Relapsed Or Refractory Multiple Myeloma: Part 2 Update Of The Open-Label, Multicenter, Dose Escalation Phase 1b Study (PAVO)
Jesus San-Miguel, Saad Z. Usmani, Maria-Victoria Mateos, Niels van de Donk, Jonathan Kaufman, Philippe Moreau, Albert Oriol, Torben Plesner, Lotfi Benboubker, Kevin Liu, Peter Hellemans, Tara Masterson, Pamela L. Clemens, Hareth Nahi, Ajai Chari (abstract)
PF556 – Levofloxacin Prophylaxis In Newly Diagnosed Myeloma Reduces Febrile Episodes And Death Without Increasing Healthcare Associated Infections: Results From The TEAMM Trial
Stella Bowcock, Tim Planche, Gulnaz Iqbal, Guy Pratt, Kwee Yong, Jill Wood, Kerry Raynes, Peter Hawkey, Janet Dunn, Mark Drayson (abstract)
PF557 – Prognostic Significance Of Magnetic Resonance Imaging Before And After Upfront Autologous Transplantation For Newly Diagnosed Multiple Myeloma – A Subgroup Analysis From The GMMG MM5 Phase III Trial
Maximilian Merz, Thomas Hielscher, Anja Seckinger, Anna Jauch, Elias Karl Mai, Uta Bertsch, Marc Steffen Raab, Kai Neben, Hans Salwender, Igor W Blau, Hans-Walter Lindemann, Jan Dürig, Christof Scheid, Mathias Haenel, Katja Weisel, Stefan Delorme, Hans Ulrich Kauczor, Dirk Hose, Hartmut Goldschmidt, Jens Hillengass (abstract)
PF558 – Phase 2 Study Of Venetoclax Plus Carfilzomib And Dexamethasone In Patients With Relapsed / Refractory Multiple Myeloma
Luciano J. Costa, Edward Stadtmauer, Gareth Morgan, Gregory Monohan, Tibor Kovacsovics, Nicholas Burwick, Andrzej Jakubowiak, Mehrdad Mobasher, Kevin Freise, Jeremy A. Ross, John Pesko, Wijith Munasinghe, Jaclyn Cordero, Lura Morris, Paulo Maciag, Orlando F. Bueno, Shaji Kumar (abstract)
PF559 – A Novel Risk-stratification Algorithm For Relapsed Multiple Myeloma (RMM): Assessment Of Performance And Validation Using Real-World Patient Data From France, Germany And The United Kingdom
Roman Hájek, Michel Delforge, Marc S. Raab, Andrew Briggs, Marco Campioni, Lucy DeCosta, Zsolt Szabo, Sonja Kroep, Walter Bouwmeester, Sebastian Gonzalez-Mcquire (abstract)
PF560 – Carfilzomib In Combination With Bendamustine And Dexamethasone In Relapsed / Refractory Multiple Myeloma: A Multicenter Phase Ib/II Trial Of The European Myeloma Network Trialist Group (EMNTG)
Francesca Gay, Massimo Offidani, Andreas Günther, Marco Salvini, Monika Engelhardt, Wolfram Poenisch, Stefano Spada, Ralph Wäsch, Vittorio Montefusco, Francesca Patriarca, Natalie Schub, Silvia Gentili, Emanuele Angelucci, Paolo Corradini, Herman Einsele, Mario Boccadoro, Pieter Sonneveld, Martin Gramatzki (abstract)
PF561 – Carfilzomib And Dexamethasone (Kd56) Vs Bortezomib And Dexamethasone (Vd) In Relapsed Or Refractory Multiple Myeloma (RRMM): Updated Overall Survival (OS), Safety, And Subgroup Analysis Of Endeavor
Robert Z. Orlowski, Philippe Moreau, Heinz Ludwig, Albert Oriol Rocafiguera, Wee Joo Chng, Hartmut Goldschmidt, Zhao Yang, Amy S. Kimball, Meletios Dimopoulos (abstract)
PF562 – Maintenance After Lenalidomide, Bortezomib, And Dexamethasone Induction And Transplant In Patients With Newly Diagnosed Multiple Myeloma And High-Risk Cytogenetics: An Enhanced Medical Record Analysis
Rafael Fonseca, Kejal Parikh, Brian Ung, Quanhong Ni, Amit Agarwal (abstract)
PF563 – European Post-Approval Safety Study In Relapsed Or Refractory Multiple Myeloma: Safety In Patients Treated With Pomalidomide In A Real-world Setting
Martin Schmidt-Hieber, Niels Abildgaard, Barbara Gamberi, Francesco Di Raimondo, Angel Ramirez Payer, Charalampia Kyriakou, Hege Froen, Antonio Izarra, Elisabeth Kueenburg, Antonia Di Micco, Barbara Rosettani, Pamela Bacon, Margaret Atiba-Davies, Torben Plesner (abstract)
PF564 – Impact Of Prior Malignancies On The Development Of Subsequent Malignancies And Survival In Multiple Myeloma: A Nationwide Population-Based Study In The Netherlands
Mirian Brink, Monique C. Minnema, Otto Visser, Annemiek Broijl, Niels W.C.J. van de Donk, Pieter Sonneveld, Sonja Zweegman, Avinash G. Dinmohamed (abstract)
PF565 – A Phase Ib Study Of Atezolizumab (Atezo) Alone Or In Combination With Lenalidomide (Len) In Patients (Pts) With Multiple Myeloma (MM)
Hearn Cho, Craig Cole, Thomas Martin, Jeffrey Zonder, Joseph Fay, John Byon, Anastasia Teterina, Cherie Green, Joanne Adamkewicz, Jeffrey M. Venstrom, Madhav Dhodapkar (abstract)
PF566 – Time To Plateau As A Predictor Of Survival In Newly Diagnosed Multiple Myeloma
Patrick Mellors, Moritz Binder, Francis Buadi, Martha Lacy, Morie Gertz, Angela Dispenzieri, Suzanne Hayman, Prashant Kapoor, Wilson Gonsalves, Yi Hwa, Amie Fonder, Miriam Hobbs, Taxiarchis Kourelis, Rahma Warsame, Steven Zeldenrust, John Lust, Nelson Leung, Ronald Go, Robert Kyle, Vincent Rajkumar, Shaji Kumar (abstract)
PF567 – Safety And Efficacy Of Pomalidomide + Low-Dose Dexamethasone Immediately Following Lenalidomide-Based Treatment Failure In Patients With Relapsed And / Or Refractory Multiple Myeloma
David S. Siegel, Gary J. Schiller, Kevin Song, Richy Agajanian, Keith Stockerl-Goldstein, Hakan Kaya, Michael Sebag, Christy Samaras, Ehsan Malek, Giampaolo Talamo, Christopher S. Seet, Jorge Mouro, Faiza Zafar, Weiyuan Chung, Shankar Srinivasan, Max Qian, Amit Agarwal, Anjan Thakurta, Nizar J. Bahlis (abstract)
PF568 – Pre-Treatment CD38 Expression Levels In Myeloma Cells And CD38-Positive Regulatory T Cells Affect The Response Of Relapsed / Refractory Multiple Myeloma Patients To Treatment With Daratumumab
Akihiro Kitadate, Hiroki Kobayashi, Yoshiaki Abe, Kentaro Narita, Masami Takeuchi, Kosei Matsue (abstract)
PF569 – Updated Results Of A Phase II Study With Carfilzomib, Cyclophosphamide And Dexamethasone (CCd) For Newly Diagnosed Transplant Ineligible Multiple Myeloma Patients.
Alessandra Larocca, Maria Teresa Petrucci, Concetta Conticello, Lorenzo De Paoli, Mattia D'Agostino, Stefano Spada, Annalisa Bernardini, Pellegrino Musto, Giulia Benevolo, Massimo Offidani, Agostina Siniscalchi, Paolo Corradini, Michele Cavo, Mario Boccadoro, Sara Bringhen (abstract)
PF570 – Development Of A Predictive Model Of Multiple Myeloma (MM) Patient Outcomes Based On Treatment (Tx) Sequencing Using Data From The Connect® MM Patient Registry
Sundar Jagannath, Robert M. Rifkin, Cristina Gasparetto, Kathleen Toomey, Brian G.M. Durie, James W. Hardin, Howard Terebelo, Lynne Wagner, Mohit Narang, Shankar Srinivasan, Ahmed YoussefAgha, Amani Kitali, Gail Larkins, Amit Agarwal, Rafat Abonour (abstract)
PF571 – External Validation Of The Multiple Myeloma (MM) Risk-Stratification Algorithm In A Real-World Greek Data Set
Evangelos Terpos, Meletios A Dimopoulos, Efstathios Kastritis, Maria Roussou, Walter Bouwmeester, Sonja Kroep, Lucy DeCosta, Marco Campioni, Zsolt Szabo, Sebastian Gonzalez-Mcquire (abstract)
PF572 – Randomized Phase II Study To Optimize Melphalan, Prednisolone And Bortezomib (MPB) In Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM): Japan Clinical Oncology Group Study (JCOG1105)
Dai Maruyama, Shinsuke Iida, Gakuto Ogawa, Shigeru Kusumoto, Suguru Fukuhara, Noriko Fukuhara, Sachiko Seo, Kana Miyazaki, Makoto Yoshimitsu, Junya Kuroda, Norifumi Tsukamoto, Hideki Tsujimura, Akira Hangaishi, Takahiro Yamauchi, Takahiko Utsumi, Ishikazu Mizuno, Yasushi Takamatsu, Yasuyuki Nagata, Koichiro Minauchi, Eiichi Ohtsuka, Ichiro Hanamura, Takashi Tokunaga, Shinichiro Yoshida, Satoshi Yamasaki, Youko Suehiro, Yutaro Kamiyama, Kenichi Miyamoto, Yuko Watanabe, Kunihiro Tsukasaki, Hirokazu Nagai (abstract)
PF573 – Real-World Treatment Patterns And Progression-Free Survival (PFS) Among Patients With Relapsed / Refractory Multiple Myeloma (RRMM) Receiving Pomalidomide-Based Regimens
Ravi Vij, Clara Chen, Catherine Davis, Hyang Kim, Hartmut Goldschmidt, Brian Durie, David Kuter (abstract)
PF574 – Time To First Onset Of Treatment-Emergent Adverse Events (TEAEs) Of Interest: A Post-Hoc Analysis From ASPIRE And ENDEAVOR Trials
Maria-Victoria Mateos, Stefan Knop, Michel Delforge, Lucy DeCosta, Florence Suzan, Zsolt Szabo, Kenneth Wang, Joseph Mikhael (abstract)
PF575 – Smoldering Myeloma After IMWG Update: Factors Predictive Of Evolution, Role Of Advanced Imaging And Of Clinical Judgement. A Real-life Retrospective Experience
Lorenza Torti, Anna Maria Morelli, Francesco Bacci, Paolo Di Bartolomeo (abstract)
PF576 – Safety Outcomes In Patients (Pts) With Relapsed / Refractory Multiple Myeloma (RRMM) Treated With Lenalidomide For ≤ 24 Months Vs > 24 Months In A European Post-Approval Safety Study (EU PASS)
Gianpietro Semenzato, Despoina Kyriakou, Phillipe Moreau, Xavier Leleu, Igor Wolfgang Blau, Argiris Symeonidis, Alberto Bosi, Elisabeth Kueenburg, Antonia Di Micco, Barbara Rosettani, Sarah Peters, Pamela Bacon, Barbara Gamberi (abstract)
PF577 – Clinical Characteristics And Outcomes Of Oligosecretory And Non-Secretory Multiple Myeloma
Magdalini Migkou, Yael Cohen, Efstathios Kastritis, Maria Gavriatopoulou, Evangelos Eleutherakis-Papaiakovou, Evangelos Terpos, Despoina Fotiou, Maria Roussou, Dimitrios C Ziogas, Evangelos Terpos, Irit Avivi, Meletios A. Dimopoulos (abstract)
PF578 – Serum Neutrophil Gelatinase-Associated Lipocalin Independently Predicts For Renal Response In Myeloma Patients With Severe Renal Impairment
Evangelos Terpos, Maria Roussou, Ioannis Papassotiriou, Maria Gavriatopoulou, Evangelos Eleutherakis-Papaiakovou, Alexandra Margeli, Despina Fotiou, Nikolaos Kanellias, Magdalini Migkou, Gerasimos-Petros Papassotoriou, Efstathios Kastritis, Meletios A Dimopoulos (abstract)
PF579 – Daratumumab, Carfilzomib, And Dexamethasone (D-Kd) In Lenalidomide-Refractory Patients With Relapsed Multiple Myeloma (MM): Subgroup Analysis Of MMY1001
Philippe Moreau, Joaquín Martinez-Lopez, Maria-Victoria Mateos, Joan Bladé, Sagar Lonial, Lotfi Benboubker, Albert Oriol, Bertrand Arnulf, Paula Rodriguez-Otero, Luis Pineiro, Andrzej Jakubowiak, Carla de Boer, Jianping Wang, Jordan Schecter, Ajai Chari (abstract)
PF580 – Long-Term Results From The HOVON-50 Study: Improved Survival With Thalidomide Before And After Transplant In Newly Diagnosed Multiple Myeloma
Niels Van De Donk, Bronno van der Holt, Monique Minnema, Edo Vellenga, Sandra Croockewit, Marie Jose Kersten, Peter von dem Borne, Paula Ypma, Ron Schaafsma, Okke de Weerdt, Saskia Klein, Michel Delforge, Mark-David Levin, Gerard Bos, Kon-Siong Jie, Harm Sinnige, Jules Coenen, Esther de Waal, Sonja Zweegman, Pieter Sonneveld, Henk Lokhorst (abstract)
PF581 – The HORIZON Study: A Preliminary Report On Efficacy And Safety Of Melflufen In Late Stage Relapsed-Refractory Myeloma (RRMM) Patients Refractory To Pomalidomide And / Or Daratumumab
Maria-Victoria Mateos, Albert Oriol Rocafiguera, Paula Rodríguez Otero, Joan Bladé, Alessandra Larocca, Jan S. Moreb, Adrián Alegre, Michele Cavo, Hani Hassoun, Amitabha Mazumder, Christopher Maisel, Agne Paner, Nashat Gabrail, Kathleen Halka, Jeffrey Zonder, Enrique M. Ocio, Catriona Byrne, Johan Harmenberg, Eva Nordstrom, Sara Thuresson, Hanan Zubair, Paul Richardson (abstract)
PF582 – Phase I-b Study Of Isatuximab + Carfilzomib In Relapsed And Refractory Multiple Myeloma (RRMM)
Joshua Richter, Sandy Wong, Ajai Chari, Nina Shah, Sundar Jagannath, Hearn Jay Cho, Noa Biran, Jeffrey Wolf, Samir Parekh, Pamela Munster, Deepu Madduri, Frank Campana, Tom Martin (abstract)
PF583 – Impact Of Baseline Renal Function On Efficacy And Safety Of Daratumumab Plus Bortezomib-Melphalan-Prednisone (VMP) In Newly Diagnosed Multiple Myeloma Patients Ineligible For Transplantation (ALCYONE)
Michele Cavo, Meletios A. Dimopoulos, Jesus San-Miguel, Andrzej Jakubowiak, Kenshi Suzuki, Sung-Soo Yoon, Mark Cook, Mario Boccadoro, P. Joy Ho, Ludek Pour, Stefan Knop, Chantal Doyen, Andre Crepaldi, Tamas Masszi, Joan Blade, Jianping Wang, Susan Wroblewski, William Deraedt, Ming Qi, Maria-Victoria Mateos (abstract)
PF584 – Update Of The Phase 2 Study Of Carfilzomib, Thalidomide, And Low-Dose Dexamethasone As Induction / Consolidation In Newly Diagnosed, Transplant Eligible Patients With Multiple Myeloma, Carthadex Trial
Ruth Wester, Bronno van der Holt, Emelie Asselbergs, Sonja Zweegman, Marie Jose Kersten, Edo Vellenga, Marinus van Marwijk Kooy, Okke de Weerdt, Monique Minnema, Sarah Lonergan, Antonio Palumbo, Henk Lokhorst, Annemiek Broijl, Karim Iskander, Pieter Sonneveld (abstract)
PF587 – Absence Of Bone Disease Is An Independent Favorable Prognostic Factor Of Overall Survival In Symptomatic Multiple Myeloma Patients Treated With Novel Agents
Eirini Katodritou, Theodora Triantafyllou, Vasiliki Palaska, Nikos Drougos, Evgenia Verrou, Konstantina Psianou, Konstantina Loga, Kyriaki Kokoviadou, Konstantina Keramidioti, Nikos Karampatzakis, Evlambia Giannopoulou, Vasiliki Gastari, Christina Chadjiaggelidou, Despina Mallouri, Georgia Kaiafa, Anna Kioumi, Achilles Anagnostopoulos, Pavlina Konstantinidou, Evangelos Terpos (abstract)
PF588 – Correlation Of 11c-Methionine-PET And FDG-PET In Multiple Myeloma With MRD Assessment By Flow Cytometry.
María Marcos, María Isabel Morales, Sara Villar, Rocío Figueroa, Luis Esteban Tamariz, Paula Rodríguez, Ana Alfonso, Ramón Lecumberri, Felipe Prosper, Carlos Panizo, Bruno Paiva, María José García-Velloso, Jesús San Miguel (abstract)
PF589 – Translocation (14;16) Positive Multiple Myeloma Patients: Clinical Features And Survival Outcomes Of A High-Risk Population.
Roberto Mina, Nisha Joseph, Francesca Gay, Ajay Nooka, Efstathios Kastritis, Stefano Spada, Maria Teresa Petrucci, Jonathan L. Kaufman, Vittorio Montefusco, Maria Gavriatopulous, Francesca Patriarca, Milena Gilestro, Lawrence H. Boise, Concetta Conticello, Sonia Grandi, maria roussou, Nicola Giuliani, Anna Marina Liberati, Dhwani Almaula, Massimo Offidani, Rossella Ribolla, David L. Jaye, Lorenzo De Paoli, Evangelos Terpos, Sagar Lonial, Mario Boccadoro, Meletios A. Dimopoulos (abstract)
PF590 – The Swedish Myeloma Registry: Increased Survival Over Time In Patients 66-80 Years Old, Diagnosed 2008-2016
Cecilie Hveding Blimark, Anna Genell, Bo Björkstrand, Kristina Carlson, Karin Forsberg, Gunnar Juliusson, Birgitta Lauri, Olle LInder, Hareth Nahi, Ronald Svensson, Ljupco Veskovski, Ingemar Turesson (abstract)
PF591 – 18f-FDG PET/CT At Diagnosis Is Useful For Determining The Survival Outcomes Of Patients With Multiple Myeloma Classified As Stage II With The Revised International Staging System
Sung-Hoon Jung, Seo-Yeon Ahn, Seung-Shin Lee, Deok-Hwan Yang, Jae-Sook Ahn, Hyeoung-Joon Kim, Je-Jung Lee (abstract)
PF592 – Haematological Diagnosis And Management In Monoclonal Gammopathy Of Renal Significance: Single Centre Experience
Ethan Troy-Barnes, Andreas Kousios, Rebecca Burrell, Neill Duncan, Terry Cook, Holger Auner, Christian Jakob, Marco Bua, Rawya Charif, Candice Roufosse, Aristeidis Chaidos (abstract)
PF593 – Ixazomib, Lenalidomide And Dexamethasone For Relapsed And Refractory Multiple Myeloma – Data From The Czech Registry Of Monoclonal Gammopathies
Jiri Minarik, Roman Hajek, Alexandra Jungova, Martin Mistrik, Tomas Pika, Evzen Gregora, Jakub Radocha, Jan Straub, Ludek Pour, Marek Wrobel, Lucie Brozova, Jaroslav Bacovsky, Petra Krhovska, Katarina Hradska, Pavel Jindra, Petr Pavlicek, Katerina Machalkova, Ivan Spicka, Martin Stork, Tomas Jelinek, Hana Plonkova, Vlastimil Scudla, Vladimir Maisnar (abstract)
PF594 – Allograft In Multiple Myeloma: Experience Of Multiple Myeloma GIMEMA Lazio Group
Federico Vozella, Anna Paola Iori, Raffaella Cerretti, Alessandro Severino, Patrizia Chiusolo, Alfonso Piciocchi, Sara Grammatico, Laura Cesini, Elena Mariggiò, Francesca Fazio, Laura Cudillo, Luca Franceschini, Tommaso Za, Simona Sica, Maria Teresa Petrucci, Valerio De Stefano, Luca De Rosa, William Arcese, Robin Foà (abstract)
PF595 – Can Standardisation Be Achieved? Assessment Of Plasma Cell Myeloma Minimal Residual Disease Testing By Flow Cytometry: An International Inter-laboratory Study
Stuart Scott, Matthew Fletcher, Liam Whitby, Constance Yuan, Leire Burgos, Silvia Mazzucchelli, Pei Lin, Ruth de Tute, Pranav Dorwal, Paul Wallace, Prasphant Tembhare, Maria Arroz, David Barnett, Andrew Chantry (abstract)
PF596 – MP0250 In Combination With Bortezomib And Dexamethasone In Patients With Relapsed-and-Refractory Multiple Myeloma: First Safety And Early Efficacy Analysis Of MP0250-CP201
Monika Szarejko, Stefan Knop, Martin Schreder, Harmut Goldschmidt, Marc S Raab, Artur Jurczyszyn, Norbert Grzasko, Jan Duerig, Barbara Gamberi, Angelo Vacca, Roberto Ria, Jutta haunschild, Christof Zitt, Frank Hermann, Keith Dawson, Andreas Harstrick, Jorge Acosta, Guy Lemaillet, Sara Bringhen (abstract)
PF597 – Statin Use Improves Myeloma-specific Survival And Is Safe To Use In Lymphoma: A Population-Based Study Of 20,464 Patients With Lymphoid Malignancies Diagnosed In Sweden 2007-2013
Elsa Brånvall, Sandra Eloranta, Sara Ekberg, Brenda M Birmann, Karin E Smedby (abstract)
PF598 – A Prospective Analysis On The Frequency And Predictive Value Of Minimal Residual Disease Assessment By Flow Cytometry And PET-CT Imaging Among Myeloma Patients On / Off Maintenance
Meral Beksac, Guldane Cengiz Seval, Ugur Sahin, Mustafa Merter, Senay Ipek, Elgin Ozkan, Klara Dalva (abstract)
PF599 – Early Relapse Is A Powerful Independent Negative Predictor For Overall Survival In Multiple Myeloma Patients Treated With Novel Agents
Eirini Katodritou, Vasiliki Palaska, Theodora Triantafyllou, Kyriaki Kokoviadou, Evgenia Verrou, Nikos Drougos, Konstantina Loga, Konstantina Psianou, Athanasia Adamoudi, Eleni Fytopoulou, Evlambia Giannopoulou, Nikos Karampatzakis, Ioannis Batsis, Konstantina Keramidioti, Sofia Georgiadou, Maria Varthaliti, Vasiliki Gastari, Christina Chadjiaggelidou, Georgia Kaiafa, Anna Kioumi, Ioanna Sakellari, Achilles Anagnostopoulos, Pavlina Konstantinidou, Evangelos Terpos (abstract)
PF600 – Sensivity And Clinical Value Of Positron Emission Tomography / Computed Tomography And Whole Body Magnetic Resonance Imaging To Assess Bone Disease In Newly Diagnosed Multiple Myeloma.
Elena Fernandez-Poveda, Valentin Cabanas-Perianes, Maria-Jose Moreno-Belmonte, Miguel Blanquer-Blanquer, Florentina Guzman-Aroca, Begoña Torregrosa-Sala, Dolores Abellán-Rivero, Andres Lopez-Sanchez, Mercedes Berenguer-Piqueras, Francesca Labbadia, Raul Perez-Lopez, Juan-Jose Cerezo-Manchado, Maria Moya-Arnao, Amelia Martinez-Marin, Begoña Navarro-Almenzar, Jose-María Moraleda-Jimenez (abstract)
| Session | Quality of Life, Palliative Care, Ethics and Health Economics |
| Type | Poster Presentations |
| Time | Friday June 15, 5:30 PM - 7:00 PM |
| Location | Poster Area |
PF685 – Real-World Outcomes Associated With Lenalidomide, Bortezomib, And Dexamethasone Versus Bortezomib And Dexamethasone In The Treatment Of Newly Diagnosed Multiple Myeloma Without Stem Cell Transplant
Kejal Parikh, Quanhong Ni, Brian Ung, Amit Agarwal, Ajai Chari (abstract)
PF687 – Quality Of Life In Newly Diagnosed And Relapsed Danish Multiple Myeloma Patients - A National Longitudinal Study Of Danish Myeloma Study Group
Lene Kongsgaard Nielsen, Mary Jarden, Christen Lykkegaard Andersen, Henrik Frederiksen, Henrik Gregersen, Anja Klostergaard, Morten Saaby Steffensen, Per Trøllund Pedersen, Bettina Broch, Mikael Frederiksen, Bo Amdi Jensen, Carsten Helleberg, Anne Kjærgaard Mylin, Niels Abildgaard (abstract)
PF694 – Erectile Disfunction In Hematological Malignancies
Frosina Krstanoska (abstract)
PF696 – Relevant Reduction Of Pomalidomide-related Neutropenia By Intensive Use Of Myeloid Growth Factor
Marina Silvia Parisi, Valeria Calafiore, Enrica Martino, Vittorio Del Fabro, Alessandra Romano, Giuseppe Sapienza, Concetta Conticello, Francesco Di Raimondo (abstract)
PF700 – A Seer-medicare Analysis Of Novel Treatment Use And Associated Outcomes Among African American Patients With Multiple Myeloma
Sikander Ailawadhi, Zoe Clancy, Zheng-Yi Zhou, Wenxi Tang, Claudia Cheung, Zhou Zhou, Jipan Xie, Kejal Parikh (abstract)
PF705 – Evaluating The Correlation Between Fatigue And Quality Of Life In Patients With Hematological Malignancies And Treated With Biosimilar Epoetin Alfa For Chemotherapy-Induced Anemia: The Ciroco Study
Kamel Laribi, Philippe Rodon, Elias Kfoury, Maya Hacini, Ravaka-Fatoma Soumoudronga, Sylvain Choquet (abstract)
| Session | Stem Cell Transplantation – Clinical |
| Type | Poster Presentations |
| Time | Friday June 15, 5:30 PM - 7:00 PM |
| Location | Poster Area |
PF720 – Carfilzomib-Cyclophosphamide-Dexamethasone Induction And Salvage ASCT In Transplant-Eligible Multiple Myeloma With First Relapse After Upfront ASCT
Henrik Gregersen, Valdas Peceliunas, Kari Remes, Fredrik Schjesvold, Niels Abildgaard, Hareth Nahi, Niels Frost Andersen, Annette Juul Vangsted, Tobias Wirenfeldt Klausen, Carsten Helleberg, Ulf Christian Frølund, Per Axelsson, Olga Stromberg, Cecilie Blimark, Kristina Carlson, Anders Waage, Markus Hansson, Nina Gulbrandsen (abstract)
PF743 – Efficacy And Safety Of Autologous Stem Cell Transplantation (ASCT) In Elderly Multiple Myeloma (MM) Patients Aged ≥ 65 Years: A Single Centre Experience
Jeremy Er, Hannah Rose, David Routledge, David Kipp, Helen Fairweather, Sumita Ratnasingam, Adam Friebe, Jenny Hempton, Philip Campbell (abstract)
PF749 – The Hematopoietic Cell Transplantation Comorbidity Index In The Context Of Autologous Stem Cell Transplantation Can Predicts Clinical Outcomes.
Alexandra Martínez-Roca, Carme Talarn Forcadel, Luis Gerardo Rodríguez-Lobato, Lourdes Escoda Teigell, Rolando Vallansot, Marta Cervera Calvo, Janilson Do Nascimento, Reyes Aguinaco Culebras, Teresa Giménez Pérez, Carmen Araguás Arasanz, Ana Vicen, Maria Sola, Josep Sarrà Escarre (abstract)
PF751 – Hematopoietic Regeneration After Autologous Stem Cell Transplantation With Actual Body Weight Based Dosing Of Conditioning Chemotherapy
David Fuchs, Rosemarie Greul, Karl Jochen Krenosz, Michael A. Fridrik (abstract)
| Session | Thrombosis and Vascular Biology & Translational Research |
| Type | Poster Presentations |
| Time | Friday June 15, 5:30 PM - 7:00 PM |
| Location | Poster Area |
PF787 – Long- Term Management Of Recurrent Venous Thromboembolism In Blood Cancer Patients At High Bleeding Risk.
Mariasanta Napolitano, Simona Raso, salvatrice mancuso, Angelica Passannanti, Marco Santoro, Lucio LoCoco, Sergio Siragusa (abstract)
| Session | Transfusion Medicine |
| Type | Poster Presentations |
| Time | Friday June 15, 5:30 PM - 7:00 PM |
| Location | Poster Area |
PF798 – Evaluation Of Oxygen Transport Of Blood In Patients With Anemia On The Background Of The Red Blood Cells Transfusions
Nikolay Romanenko, Alexander Chechetkin, Galina Grishina (abstract)